Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Radiance Therapeutics logo — Next-generation ophthalmic beta therapy

Radiance Therapeutics

Next-generation ophthalmic beta therapy

Founded 2018 United States Emeryville, United States 9 employees Series Unknown Total: $7.19M Biotechnology, Health Care +1

General Information

Company Name Radiance Therapeutics
Founded Year 2018
Location United States Emeryville, United States +2
Founders / Decision Makers
Team member
Employees 9
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when Radiance Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Radiance Therapeutics

Radiance Therapeutics is a biotechnology startup founded in 2018, based in the United States. With the slogan "Next-generation ophthalmic beta therapy," this company is focused on developing a next-generation ophthalmic beta therapy applicator. Recently, Radiance Therapeutics received a significant boost with a $6.19M Venture Round investment on 09 January 2019. This investment not only underscores the potential of Radiance Therapeutics but also demonstrates investor confidence in the future of ophthalmic beta therapy. The absence of specific information on the investors behind this funding round can be seen as an opportunity for venture capitalists to inquire about potential involvement in this innovative and promising venture. With the increasing importance of biotechnology and healthcare, Radiance Therapeutics represents a forward-looking investment opportunity. As ophthalmic treatments continue to evolve, the potential impact of Radiance Therapeutics in this field is substantial. This startup is one to watch for its potential to make significant advancements in ophthalmic therapy, making it an attractive prospect for venture capitalists seeking to invest in innovative healthcare solutions.

Taxonomy: ophthalmic beta therapy, Radiance Therapeutics, next-generation, applicator, ophthalmology, eye treatment, innovation, biomedical devices

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 09 Jan 2019
Seed Round •••••• - 31 Jul 2018

FAQ About Radiance Therapeutics

Next-generation ophthalmic beta therapy
Radiance Therapeutics was founded in 2018.
Radiance Therapeutics is headquartered in Emeryville, United States.
Radiance Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Radiance Therapeutics has approximately 9 employees.
Radiance Therapeutics has completed 2 funding rounds, raising a total of $7.19M. The latest funding stage is Series Unknown.

We're actively collecting intelligence on Radiance Therapeutics.

Track Radiance Therapeutics to get notified

Don't just browse. Track.

Signal Tracker monitors Radiance Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy